renin binding protein ; Homo sapiens






446 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1587805 Modulation of active renin secretion by renin-binding protein (RnBP) in mouse pituitary AtT-20 cells transfected with human renin and RnBP cDNAs. J Biochem 1992 Mar 1
2 2182620 Molecular cloning and sequence analysis of a cDNA encoding a porcine kidney renin-binding protein. J Biol Chem 1990 Apr 25 3
3 2300246 Mortality associated with early and late levodopa therapy initiation in Parkinson's disease. Neurology 1990 Feb 1
4 2440622 Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zellweger) syndrome. Clin Chim Acta 1987 Jun 30 4
5 3052455 Characterization of hog kidney renin-binding protein: interconversion between monomeric and dimeric forms. Biochem Int 1988 Jun 15
6 5522468 Regulatory role of adenosine triphosphate on hog kidney N-acetyl-D-glucosamine 2-epimerase. Biochemistry 1970 Aug 18 1
7 6341368 Purification of high molecular weight (HMW) renin from porcine kidney and direct evidence that the HMW renin is a complex of renin with renin binding protein (RnBP). J Biochem 1983 Jan 3
8 6885739 Purification and characterization of renin binding protein (RnBP) from porcine kidney. J Biochem 1983 Jun 8
9 7028769 Demonstration of the formation of renin and renin-binding protein complex using high-performance liquid chromatography. J Chromatogr 1981 Oct 9 1
10 7585153 Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med 1995 Jul 1
11 7748463 The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm Park Dis Dement Sect 1994 1
12 9406739 Age and cognitive impairment influence the performance of the General Health Questionnaire. Compr Psychiatry 1997 Nov-Dec 2
13 9650745 Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain. Acta Neuropathol 1998 Jun 2
14 9666048 Age-related neurodegeneration and oxidative stress: putative nutritional intervention. Neurol Clin 1998 Aug 2
15 9712016 Age and causes of death in adult-onset myotonic dystrophy. Brain 1998 Aug 1
16 9990133 Human renin-binding protein is the enzyme N-acetyl-D-glucosamine 2-epimerase. J Biochem 1999 Feb 2
17 10334995 UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science 1999 May 21 1
18 10356312 Sialuria in a Portuguese girl: clinical, biochemical, and molecular characteristics. Mol Genet Metab 1999 Jun 1
19 10502668 Identification of cysteine-380 as the essential residue for the human N-acetyl-D-glucosamine 2-epimerase (renin binding protein). J Biochem 1999 Oct 10
20 10654103 Investigations on oxidative stress and therapeutical implications in dementia. Eur Arch Psychiatry Clin Neurosci 1999 2
21 10821439 Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J Neural Transm (Vienna) 2000 1
22 11098137 Renin inhibits N-acetyl-D-glucosamine 2-epimerase (renin-binding protein). J Biochem 2000 Dec 2
23 11275551 Identification of functionally important cysteine residues of the human renin-binding protein as the enzyme N-acetyl-D-glucosamine 2-epimerase. J Biochem 2001 Apr 2
24 11425505 A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology 2001 Aug 3
25 11578838 Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism. Neurosci Lett 2001 Oct 12 11
26 11726282 Effects of nucleotides on N-acetyl-d-glucosamine 2-epimerases (renin-binding proteins): comparative biochemical studies. J Biochem 2001 Dec 10
27 11828884 Protein "AGEing"--cytotoxicity of a glycated protein increases with its degree of AGE-modification. Z Gerontol Geriatr 2001 Dec 1
28 11926999 Identification of a domain conferring nucleotide binding to the N-acetyl-d-glucosamine 2-epimerase (Renin binding protein). J Biochem 2002 Apr 4
29 12392783 Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002 Sep-Oct 2
30 12454953 Age and severity of nigrostriatal damage at onset of Parkinson's disease. Synapse 2003 Feb 3
31 12479964 Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study. Pharmacol Biochem Behav 2003 Jan 1
32 12499362 GlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolism. J Biol Chem 2003 Mar 7 7
33 12927803 Epigenetically mediated loss of UDP-GlcNAc 2-epimerase/ManNAc kinase expression in hyposialylated cell lines. Biochem Biophys Res Commun 2003 Sep 5 4
34 14750790 Novel UDP-glycal derivatives as transition state analogue inhibitors of UDP-GlcNAc 2-epimerase. J Org Chem 2004 Feb 6 5
35 15221334 Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease. Acta Neuropathol 2004 Sep 22
36 15383512 Age-related testosterone depletion and the development of Alzheimer disease. JAMA 2004 Sep 22 1
37 15453416 Hydroxyapatite-based immobilized metal affinity adsorbents for protein purification. J Chromatogr A 2004 Sep 3 3
38 16037241 Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci 2005 Jun 3
39 16291936 Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 2005 Nov 16 1
40 16696946 Age-dependent oxidative stress-induced DNA damage in Down's lymphocytes. Biochem Biophys Res Commun 2006 Jun 30 2
41 16793534 Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov Today 2006 Jul 3
42 17023685 Effects of nucleotides on the interaction of renin with GlcNAc 2-epimerase (renin binding protein, RnBP). J Biochem 2006 Nov 3
43 17315096 [Predictive clinical factors of response to subthalamic nucleus stimulation in Parkinson's disease]. Neurologia 2007 Jan-Feb 1
44 17331665 Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders. Med Hypotheses 2007 4
45 18653764 Allele-specific silencing of the dominant disease allele in sialuria by RNA interference. FASEB J 2008 Nov 1
46 19841673 Crystal structure of the N-acetylmannosamine kinase domain of GNE. PLoS One 2009 Oct 20 1
47 20186922 The sour side of neurodegenerative disorders: the effects of protein glycation. J Pathol 2010 May 2
48 21320609 Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine. Neuroimage 2011 Jun 1 1
49 21874328 Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease. Acta Neuropathol 2011 Nov 1
50 22402719 [Sialic Acid supplementation therapy for distal myopathy with rimmed vacuoles]. Brain Nerve 2012 Mar 1